Novascreen Biosciences Corporation

Hanover, MD 21076

SBIR Award Summary

Total Number of Awards 22
Total Value of Awards $7.12MM
First Award Date 09/01/96
Most Recent Award Date 08/01/07

Key Personnel

Last Name Name Awards Contact
Chmurny Alan B Chmurny 1
Glaeser Bruce S Glaeser 1
Liu Ming Liu 1
Chen Hao Chen 11
Perschke Scott E Perschke 3
Wang Fong L Wang 1
Weissman Arthur David Weissman 3
Weissman Arrthur David Weissman 1

22 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-03-54
Budget: 08/01/07 - 07/31/08
PI: Hao Chen

DESCRIPTION (provided by applicant): Cocaine addiction and dependency have reached pandemic levels and have become a continuing national healthcare concern. At present, no effective and safe medication is available to treat cocaine dependency and to ameliorate the underlying chemical addiction. During previous SBIR Phase I and Phase II supported...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-03-54
Budget: 08/01/06 - 07/31/07
PI: Hao Chen

DESCRIPTION (provided by applicant): Cocaine addiction and dependency have reached pandemic levels and have become a continuing national healthcare concern. At present, no effective and safe medication is available to treat cocaine dependency and to ameliorate the underlying chemical addiction. During previous SBIR Phase I and Phase II supported...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AA-04-02
Budget: 02/01/06 - 01/31/07
PI: Hao Chen

DESCRIPTION (provided by applicant): NovaScreen Biosciences Corp. has successfully completed a Phase I SBIR project (#1 R43 AA014542-01, entitled "Novel Molecules to Treat Alcoholism") and is submitting this Phase II SBIR application in response to RFA-AA-04-002, "Medications Development to Treat Alcoholism." The specific objective of this Phas...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-03-54
Budget: 09/01/05 - 07/31/06
PI: Hao Chen

DESCRIPTION (provided by applicant): Cocaine addiction and dependency have reached pandemic levels and have become a continuing national healthcare concern. At present, no effective and safe medication is available to treat cocaine dependency and to ameliorate the underlying chemical addiction. During previous SBIR Phase I and Phase II supported...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-75
Budget: 08/01/05 - 07/31/07

DESCRIPTION (provided by applicant): The goal of this project is to establish predictive algorithms useful for drug discovery and development covering six potassium (K+) channels that are important targets associated with potential cardiotoxicity of drugs. To accomplish this larger goal, we first plan to establish a clonal cell line that het...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/10/05 - 12/31/06
PI: Hao Chen

DESCRIPTION (provided by applicant): Cystic Fibrosis (CF) is a lethal genetic disease characterized in part by one or more mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Mutations of the CFTR protein, typically a deletion of a phenylalanine at position 508 (deltaF508), disable the chloride ion transport activity of ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AA-04-02
Budget: 02/01/05 - 01/31/06
PI: Hao Chen

DESCRIPTION (provided by applicant): NovaScreen Biosciences Corp. has successfully completed a Phase I SBIR project (#1 R43 AA014542-01, entitled "Novel Molecules to Treat Alcoholism") and is submitting this Phase II SBIR application in response to RFA-AA-04-002, "Medications Development to Treat Alcoholism." The specific objective of this Phas...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/04 - 04/30/06

DESCRIPTION (provided by applicant): The goal of this NIH SBIR Phase II Grant Application is to expand and validate the pilot in vitro neurotoxicity database that was constructed during a Phase I SBIR Grant. The toxicity database will be used to aid in evaluating the safety characteristics of new chemical compounds that may be therapeutically ad...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-75
Budget: 08/01/04 - 07/31/05

DESCRIPTION (provided by applicant): The goal of this project is to establish predictive algorithms useful for drug discovery and development covering six potassium (K+) channels that are important targets associated with potential cardiotoxicity of drugs. To accomplish this larger goal, we first plan to establish a clonal cell line that het...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AA-03-05
Budget: 09/05/03 - 02/29/04
PI: Hao Chen

DESCRIPTION (provided by applicant): Current treatments for alcohol abuse and dependency are marginally effective. Application of naltrexone, an opiate antagonist, appears to have only a moderate effect in reducing drinking and is not sufficiently effective in treating some sub-populations of problematic alcohol consumers or in preventing relap...

Load More